Delivery Order SPE2DR25D1202-SPE2DR26F74AE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20 units, with a ceiling value of $3,332.36 and an ultimate completion date of January 8, 2026. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count) with a ceiling value of $1,838.12. This competitive delivery order utilizes firm fixed-price terms and is scheduled for completion by March 12, 2025. The contract does not carry a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Amoxicillin-Clavulanate 250-125 mg tablets (30-count packages) with a ceiling value of $1,498.72. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amoxicillin-clavulanate suspension (400-57 mg/5 ml, 100 ml) under a firm fixed-price contract with a ceiling value of $1,170.97. The award, issued on September 19, 2025, is a non-set-aside competitive procurement with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Amoxicillin 875 mg tablets in quantities of 100 units. This firm fixed-price contract, valued at $1,020.36, represents a non-competitive delivery order with an ultimate completion date of January 16, 2026. The award was issued under a competitive basis with no set-aside designation. Performance will be executed from the company's corporate office in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order, valued at $3,341.13, is for the supply of 4,559,578,371 units of Amoxicillin-Clavulanate 500-125 mg tablets in 20-count packages. The contract is a firm-fixed-price delivery order with a completion date of January 12, 2023. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as part of its larger...
- The Defense Logistics Agency awarded a delivery order valued at $368.18 to Amerisourcebergen Drug Corp under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for 4561969007 units of Amoxicillin-Clavulanate 875-125 mg tablets to be delivered by August 29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price contract has no set aside designation. As a major supplier of pharmaceuticals to the DOD, this...
- The Defense Logistics Agency Troop Support Medical awarded a $1,003.89 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 1,000-62.5 mg tablets of amoxicillin-clavulanate potassium. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The firm fixed price order is for product delivery between August 7-8, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp Corporate Office Division, which will...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74AEDelivery Order
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,220.22 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (100 count). This non-competitive, firm fixed-price delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. The award represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vehicle extending through December 2026 that enables comprehensive pharmaceutical and medical supply support for military healthcare systems globally. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company holds the capacity to deliver a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a non-set-aside award, this delivery order was competitively awarded and reflects AmerisourceBergen's established capability to efficiently fulfill essential pharmaceutical requirements for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/14/26 |